Cellular Engineering Technologies
US-based Cellular Engineering Technologies, Inc. specializes in commercial physical and biological R&D since 2000.
Founded
2000US-based Cellular Engineering Technologies, Inc. specializes in commercial physical and biological R&D since 2000.
Cellular Engineering Technologies, Inc., founded in 2000 and based in Coralville, United States, focuses on addressing the technical and clinical challenges of next-generation cell therapies and regenerative medicines. The company offers optimized reagents, cell lines, scalable technologies, and custom solutions to streamline cell therapy protocols. Their products include human growth factors and cytokines from human expression models, differentiated stem cell lines, and a range of customized services.
The company has made significant strides in providing safer methods and scalable technologies designed to assist scientists and process development professionals. By focusing on commercial physical and biological research and development, Cellular Engineering Technologies has established itself as a key player in the field of regenerative medicine, contributing to advancements that support both clinical and research applications.
Companies similar to Cellular Engineering Technologies include Celltheon, CDI Bioscience, Celularity and Cellebration Life Sciences.
Cellular Engineering Technologies was founded in 2000.
Cellular Engineering Technologies' headquarters is located in Coralville, IA, US.
Cellular Engineering Technologies' most recent funding round was for $30k (USD) in January 2014.
As of Jan 24, 2014, Cellular Engineering Technologies has disclosed funding of $30k (USD). Undisclosed round amounts are excluded.
Cellular Engineering Technologies has 9 employees as of Feb 5, 2024.
Cellebration Life Sciences
